Although most of the studies reported a positive correlation between BrCa progression and activity of IDO1 [102–115], one study showed the opposite observation [114] while another reported no significant differences in the expression of IDO1 between cancerous and non-cancerous tissues [116]. This evidence concerns the gene IDO1 and invasive breast carcinoma.